Atlas Trials

Abiraterone-Rechallenge Study for CRPC Patients

Clinical trial NCT02656615 · TERMINATED

Trial details

NCT number
NCT02656615
Sponsor
Aurelius Omlin
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-01-01
Primary completion
2017-02-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.